- Home
- JNJ vs SAN Comparison
JNJ vs SAN Comparison
Compare JNJ & SAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JNJ | SAN |
|---|---|---|
| Founded | 1886 | 1857 |
| Country | United States | Spain |
| Employees | N/A | 186370 |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.4B | 179.7B |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | JNJ | SAN |
|---|---|---|
| Price | $240.38 | $13.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 1 |
| Target Price | ★ $238.20 | N/A |
| AVG Volume (30 Days) | 7.4M | ★ 8.4M |
| Earning Date | 04-14-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.36% | 1.54% |
| EPS Growth | ★ 90.50 | N/A |
| EPS | ★ 2.14 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.63 | $34.53 |
| Revenue Next Year | $7.43 | $6.55 |
| P/E Ratio | $111.72 | ★ $11.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $151.01 | $8.19 |
| 52 Week High | $251.71 | $13.78 |
Technical Indicators
Market Signals| Indicator | JNJ | SAN |
|---|---|---|
| Relative Strength Index (RSI) | 60.83 | 60.59 |
| Support Level | $233.83 | $11.75 |
| Resistance Level | $244.80 | N/A |
| Average True Range (ATR) | 4.73 | 0.26 |
| MACD | 0.53 | 0.10 |
| Stochastic Oscillator | 86.93 | 76.20 |
Price Performance
Historical ComparisonAbout JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
About SAN Banco Santander S.A. Sponsored ADR (Spain)
Santander's focus is on retail and commercial banking. Latin America is geographically the most significant operation, with Brazil making the largest contribution. Its continental European business is mainly in Spain and Portugal. Santander's UK presence is the result of its acquisition of Abbey building society. In the US, Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.